The Hercules gene: a rare mutation that makes babies unusually muscular—and what it could mean for medicine
A rare human mutation in myostatin (GDF-8) removes the body's brake on muscle growth, producing infants with remarkable muscle mass and strength—cases linked to a German boy and even similar effects seen in dogs—sparking decades of research and the search for therapies that block myostatin. Yet as scientists pursued myostatin inhibitors for muscle-wasting diseases, results were largely disappointing. In 2026, a trial combining a myostatin blocker with tirzepatide for obesity showed lean-mass preservation but no clear functional gains, highlighting both the potential and the limits of applying this biology to medicine.